The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
An investigation into the human serum “interactome”
Abstract
The protein content of human serum is composed of a millieu of proteins from almost every type of cell and tissue within the body. The serum proteome has been shown to contain information that directly reflects pathophysiological states and represents an invaluable source of diagnostic information for a variety of different diseases. Unfortunately, the dynamic range of protein abundance, ranging from ≫ mg/mL level to ≪ pg/mL level, renders complete characterization of this proteome nearly impossible with current analytical methods. To study low‐abundance proteins, which have potential value for clinical diagnosis, the high‐abundant species, such as immunoglobulins and albumin, are generally eliminated as the first step in many analytical protocols. This step, however, is hypothesized to concomitantly remove proteins/peptides associated with the high‐abundant proteins targeted for depletion. In this study, immunoprecipitation was combined with microcapillary reversed‐phase liquid chromatography (μRPLC) coupled on‐line with tandem mass spectrometry (MS/MS) to investigate the low‐molecular‐weight proteins/peptides that associate with the most abundant species in serum. By this targeted isolation of select highly abundant serum proteins, the associated proteins/peptides can be enriched and effectively identified by μRPLC‐MS/MS. Among the 210 proteins identified, 73% and 67% were not found in previous studies of the low‐molecular‐weight or whole‐serum proteome, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationLi, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Self-citationToward a Human Blood Serum Proteome
Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., & Pounds, J. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200066-mcp200 · Cited by 793
Serum Proteomic Patterns for Detection of Prostate Cancer
Petricoin, E. F. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1576 · Cited by 736
Self-citationBiology of Prostate-Specific Antigen
Balk, S. P., Ko, Y.-J., & Bubley, G. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.083 · Cited by 718
Pieper, R., Gatlin, C. L., Makusky, A. J., Russo, P. S., Schatz, C. R., Miller, S. S., Su, Q., McGrath, A. M., Estock, M. A., Parmar, P. P., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300449 · Cited by 518
Qu, Y., Adam, B.-L., Yasui, Y., Ward, M. D., Cazares, L. H., Schellhammer, P. F., Feng, Z., Semmes, O. J., & Wright, G. L. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.10.1835 · Cited by 433
Cited by
Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Petricoin, E. F., Belluco, C., Araujo, R. P., & Liotta, L. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2011 · Cited by 357
Self-citationApplication of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
Jin, C., Wang, K., Oppong-Gyebi, A., & Hu, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49801 · Cited by 353
States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D., Eng, J., Speicher, D. W., & Hanash, S. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1183 · Cited by 325
Issaq, H. J., Xiao, Z., & Veenstra, T. D. (2007) · Chemical Reviews · doi:10.1021/cr068287r · Cited by 315
Self-citationDifferences among techniques for high‐abundant protein depletion
Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J., Boyes, B. E., & Barrett, W. C. (2005) · PROTEOMICS · doi:10.1002/pmic.200402021 · Cited by 282
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 278
High-resolution serum proteomic features for ovarian cancer detection.
Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., et al. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110163 · Cited by 260
Self-citation
Metadata
- Authors
- Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J., Petricoin, E. F., Liotta, L. A., Veenstra, T. D., & Conrads, T. P.
- Venue
- ELECTROPHORESIS
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 25
- Issue
- 9
- Pages
- 1289-1298
- ISSN
- 0173-0835 (ISSN-L)
- 1522-2683
- OpenAlex
- W1992730111
- Cited by
- 313
- References
- 36
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.